Wolseley acquires New York plumbing supplier
Wolseley, the FTSE 100 plumbers' merchant, has acquired Davis & Warshow, a residential and commercial plumbing supplier in the New York metropolitan area.
Wolseley, the FTSE 100 plumbers' merchant, has acquired Davis & Warshow, a residential and commercial plumbing supplier in the New York metropolitan area.
The purchase was made for a cash consideration of £49m.
In the year ended December 31st 2011 the business generated revenue of £72m and trading profit of £5.3m. The net assets acquired were £24m.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The business, which operates from 11 locations, including seven plumbing branches and three stand alone showrooms, will be integrated with Wolseley's US Blended Branches business.
"The acquisition of a long-standing, well-respected business such as Davis & Warshow allows us to enter the greater New York City area, where we have historically been under-represented," said Wolseley Chief Executive Officer Ian Meakins.
"It also provides a solid platform for future growth and expansion in this large and attractive market."
The share price nudged 0.07% higher to 2,690p in the hour following the announcement.
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published